Liraglutide and the Risk of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes: Nissen, S
From skin and hair research to tissue repair and inflammation modulation, it continues to demonstrate relevance across multiple disciplines
Mann, MD, Professor of Medicine, Friedrich Alexander University of Erlangen-Nrnberg and Head of KfH Kidney Centre, Munich, Germany, will discuss the safety outcomes
Inhaled insulin for diabetes mellitus
Accordingly, Masson staining revealed that recombinant CXCL10 treatment sharply increased fibrosis in the CXCL10 group, whereas IL18R1 antibody treatment reversed fibrosis to levels close to those of the control in the 10+18ab group (Fig
278 , e430e439 (2023)